Study of Debio 1450 for Bacterial Skin Infections

Completed · Phase 2 · Has a placebo group

Conditions studied: Bacterial Infections

In brief

The primary objective of this study is to evaluate the efficacy of 2 different doses of intravenous and oral Debio 1450 compared with intravenous vancomycin and oral linezolid in the treatment of patients with staphylococcal ABSSSI.

Key facts

Study ID
NCT02426918
Run by
Debiopharm International SA
People needed
330
Starts
2015-05-01
Expected to finish
2016-09-01
Last updated by the study team
2019-11-13

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.